CEP135 Antikörper (AA 1050-1130)
Kurzübersicht für CEP135 Antikörper (AA 1050-1130) (ABIN7226060)
Target
Alle CEP135 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- AA 1050-1130
-
Verwendungszweck
- Rabbit Anti-CEP135 Polyclonal Antibody
-
Spezifität
- CEP135 Polyclonal Antibody detects endogenous levels of CEP135 protein.
-
Aufreinigung
- The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen.
-
Immunogen
- Synthesized peptide derived from the C-terminal region of human CEP135 at AA range: 1050-1130
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Optimal working dilutions should be determined experimentally by the investigator. Suggested starting dilutions are as follows: WB 1:500-1:2000,IHC 1:100-1:300,ELISA 1:40000,IF 1:50-200
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 1 mg/mL
-
Buffer
- Liquid in PBS containing 50 % glycerol, 0.5 % BSA and 0.02 % sodium azide.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
Informationen zur Lagerung
- Stable for one year at -20°C from date of shipment. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap. Aliquot to avoid repeated freezing and thawing.
-
Haltbarkeit
- 12 months
-
-
- CEP135 (Centrosomal Protein 135kDa (CEP135))
-
Andere Bezeichnung
- CEP135
-
Hintergrund
- CEP135, CEP4, KIAA0635, Centrosomal protein of 135 kDa, Cep135, Centrosomal protein 4CEP135 (centrosomal protein 135) encodes a centrosomal protein, which acts as a scaffolding protein during early centriole biogenesis, and is also required for centriole-centriole cohesion during interphase. Mutations in CEP135 are associated with autosomal recessive primary microcephaly-8.
-
Molekulargewicht
- 134kD
-
Gen-ID
- 9662
-
UniProt
- Q66GS9
-
Pathways
- M Phase, SARS-CoV-2 Protein Interaktom
Target
-